Fundraising Fox3D Bio Holdings
Brooklyn, US · Founded 2014 · Delaware corporation
Find your way into 3D Bio Holdings
Sign up to see every warm intro you have to 3D Bio Holdings
- Paths you didn't know you had: your email and LinkedIn already hold routes to the 3D Bio Holdings team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
DL
Daniel L. CohenNamed on SEC filing
Board
MA
Matthew A. FitzpatrickBoard director
HF
Harlan F. WeismanBoard director
MG
Michael G. BatorBoard director
Reported raises · per SEC filings
Form D private placements$8.5M disclosed across 5 rounds · 2015–2019
▶$5MraisedApr 2019 · 9 investors · BiotechnologyRule 506(b)
▶$5MraisedApr 2019 · 9 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Matthew A. FitzpatrickDirector
- Harlan F. WeismanDirector
- Michael G. BatorDirector
- Daniel L. CohenExecutive Officer, Director
- Offering amount
- $15M
- Amount sold
- $5M
- First sale
- Feb 2019
- Incorporated
- Corporation, Delaware, 2014
- Federal exemptions
- 06b
▶$2.2MraisedJul 2017 · 1 investors · BiotechnologyRule 506(c)
▶$2.2MraisedJul 2017 · 1 investors · Biotechnology
Rule 506(c)Officers, directors & promoters on the filing
- MATTHEW A. FITZPATRICKDirector
- HARLAN F. WEISMANDirector
- DANIEL L. COHENExecutive Officer, Director
- MICHAEL G. BATORDirector
- Offering amount
- $2.5M
- Amount sold
- $2.2M
- First sale
- Jun 2017
- Incorporated
- Limited Liability Company, Delaware, 2014
- Federal exemptions
- 06c
▶$25KraisedApr 2017 · 1 investors · BiotechnologyRule 506(c)
▶$25KraisedApr 2017 · 1 investors · Biotechnology
Rule 506(c)Officers, directors & promoters on the filing
- Matthew A. FitzpatrickDirector
- Michael G. BatorDirector
- Harlan F. WeismanDirector
- Daniel L. CohenExecutive Officer, Director
- Offering amount
- $1.5M
- Amount sold
- $25K
- First sale
- Mar 2017
- Incorporated
- Limited Liability Company, Delaware, 2014
- Federal exemptions
- 06c
▶$500KraisedAug 2016 · 2 investors · BiotechnologyRule 506(b)
▶$500KraisedAug 2016 · 2 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Harlan F. WeismanDirector
- Michael G. BatorDirector
- Daniel L. CohenExecutive Officer, Director
- Matthew A. FitzpatrickDirector
- Offering amount
- $1M
- Amount sold
- $500K
- First sale
- May 2016
- Incorporated
- Limited Liability Company, Delaware, 2014
- Federal exemptions
- 06b
▶$705KraisedMay 2016 · 17 investors · BiotechnologyRule 506(b)
▶$705KraisedMay 2016 · 17 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Matthew A. FitzpatrickDirector
- Michael G. BatorDirector
- Harlan F. WeismanDirector
- Daniel L. CohenExecutive Officer, Director
- Offering amount
- $2.5M
- Amount sold
- $705K
- First sale
- Dec 2015
- Incorporated
- Limited Liability Company, Delaware, 2014
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has 3D Bio Holdings raised?
- 3D Bio Holdings has disclosed $8.5M raised across 5 rounds.
- Where is 3D Bio Holdings headquartered?
- 3D Bio Holdings is headquartered in Brooklyn, US.